Literature DB >> 32539234

Genetic Manipulation and Virulence Assessment of Fusobacterium nucleatum.

Emily A Peluso1, Matthew Scheible1, Hung Ton-That1, Chenggang Wu2.   

Abstract

Considered a commensal, the Gram-negative anaerobe Fusobacterium nucleatum is a key member of the oral microbiome due to its wide range of interactions with many oral microbes. While the periodontal pathogenic properties of this organism have widely been examined, its connotation with extra-oral infections, including preterm birth and colorectal cancer, has now become apparent. Nonetheless, little is known about the mechanisms of pathogenicity and the associated virulence factors of F. nucleatum, most likely due to limited genetic tools and facile methodology. Here, we describe molecular techniques for the genetic manipulation of F. nucleatum, including markerless, nonpolar gene deletion, complementation, and Tn5 transposon mutagenesis. Further, we provide methodology to assess virulence potential of F. nucleatum using a mouse model of preterm birth.
© 2020 Wiley Periodicals LLC. Basic Protocol 1: Generation of a galK mutant strain Basic Protocol 2: Complementation of a mutant strain Basic Protocol 3: Tn5 transposon mutagenesis of F. nucleatum Basic Protocol 4: Mouse model of preterm birth. © 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Fusobacterium nucleatum; gene deletion; infection model; preterm birth; transposon mutagenesis

Mesh:

Substances:

Year:  2020        PMID: 32539234      PMCID: PMC7398570          DOI: 10.1002/cpmc.104

Source DB:  PubMed          Journal:  Curr Protoc Microbiol        ISSN: 1934-8525


  18 in total

1.  Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatum.

Authors:  T Wu; L Cen; C Kaplan; X Zhou; R Lux; W Shi; X He
Journal:  J Dent Res       Date:  2015-07-07       Impact factor: 6.116

2.  Coaggregation of Candida albicans with oral Fusobacterium species.

Authors:  N J Grimaudo; W E Nesbitt
Journal:  Oral Microbiol Immunol       Date:  1997-06

3.  Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.

Authors:  Susan Bullman; Chandra S Pedamallu; Ewa Sicinska; Thomas E Clancy; Xiaoyang Zhang; Diana Cai; Donna Neuberg; Katherine Huang; Fatima Guevara; Timothy Nelson; Otari Chipashvili; Timothy Hagan; Mark Walker; Aruna Ramachandran; Begoña Diosdado; Garazi Serna; Nuria Mulet; Stefania Landolfi; Santiago Ramon Y Cajal; Roberta Fasani; Andrew J Aguirre; Kimmie Ng; Elena Élez; Shuji Ogino; Josep Tabernero; Charles S Fuchs; William C Hahn; Paolo Nuciforo; Matthew Meyerson
Journal:  Science       Date:  2017-11-23       Impact factor: 47.728

4.  Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes.

Authors:  Christopher W Kaplan; Xiaoyuan Ma; Avina Paranjpe; Anahid Jewett; Renate Lux; Susan Kinder-Haake; Wenyuan Shi
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

Review 5.  Fusobacterium nucleatum: a commensal-turned pathogen.

Authors:  Yiping W Han
Journal:  Curr Opin Microbiol       Date:  2015-01-08       Impact factor: 7.934

6.  Actinobacillus actinomycetemcomitans serotype b lipopolysaccharide mediates coaggregation with Fusobacterium nucleatum.

Authors:  Graciela Rosen; Ira Nisimov; Monica Helcer; Michael N Sela
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.

Authors:  Jawad Abed; Johanna E M Emgård; Gideon Zamir; Mouhammad Faroja; Gideon Almogy; Amalie Grenov; Asaf Sol; Ronit Naor; Eli Pikarsky; Karine A Atlan; Anna Mellul; Stella Chaushu; Abigail L Manson; Ashlee M Earl; Nora Ou; Caitlin A Brennan; Wendy S Garrett; Gilad Bachrach
Journal:  Cell Host Microbe       Date:  2016-08-10       Impact factor: 21.023

8.  Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth.

Authors:  Yiping W Han; Raymond W Redline; Mei Li; Lihong Yin; Gale B Hill; Thomas S McCormick
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm.

Authors:  Christopher W Kaplan; Renate Lux; Susan Kinder Haake; Wenyuan Shi
Journal:  Mol Microbiol       Date:  2008-11-07       Impact factor: 3.501

10.  Forward Genetic Dissection of Biofilm Development by Fusobacterium nucleatum: Novel Functions of Cell Division Proteins FtsX and EnvC.

Authors:  Chenggang Wu; Abu Amar Mohamed Al Mamun; Truc Thanh Luong; Bo Hu; Jianhua Gu; Ju Huck Lee; Melissa D'Amore; Asis Das; Hung Ton-That
Journal:  MBio       Date:  2018-04-24       Impact factor: 7.867

View more
  4 in total

1.  Genetic and molecular determinants of polymicrobial interactions in Fusobacterium nucleatum.

Authors:  Chenggang Wu; Yi-Wei Chen; Matthew Scheible; Chungyu Chang; Manuel Wittchen; Ju Huck Lee; Truc T Luong; Bethany L Tiner; Andreas Tauch; Asis Das; Hung Ton-That
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

2.  Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome.

Authors:  Wen-Bing Jin; Ting-Ting Li; Da Huo; Sophia Qu; Xin V Li; Mohammad Arifuzzaman; Svetlana F Lima; Hui-Qing Shi; Aolin Wang; Gregory G Putzel; Randy S Longman; David Artis; Chun-Jun Guo
Journal:  Cell       Date:  2022-01-19       Impact factor: 41.582

3.  The Fused Methionine Sulfoxide Reductase MsrAB Promotes Oxidative Stress Defense and Bacterial Virulence in Fusobacterium nucleatum.

Authors:  Cuong T Nguyen; Truc Thanh Luong; Ju Huck Lee; Matthew Scheible; Yi-Wei Chen; Chungyu Chang; Manuel Wittchen; Martha I Camacho; Bethany L Tiner; Chenggang Wu; Andreas Tauch; Asis Das; Hung Ton-That
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

Review 4.  Colorectal cancer: the facts in the case of the microbiota.

Authors:  Slater L Clay; Diogo Fonseca-Pereira; Wendy S Garrett
Journal:  J Clin Invest       Date:  2022-02-15       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.